Retail trading frenzy sinks major indexes, J&J and Novavax positive vaccine news, Gold’s volatile session

Ed Moya MarketPulse

Unprecedented trading activity over the past week delivered a rare victory to the small retail trader and crushing defeat to hedge funds and giant short-sellers. Wall Street watched in awe as companies with terrible fundamentals saw relentless option buying by retail investors take advantage of a structural weakness in markets. The battle over GameStop is far from over but there have been huge casualties. Citron Research announced that after 20 years of providing short-selling research, they are shifting to focusing on long side opportunities. Some hedge funds required rescue financing and some retail traders mistimed the meteoric rise in many stocks.

In a busy trading week that contained a FOMC decision, Apple’s supercycle earnings results, and a plethora of news on the COVID, financial markets remained fixated on GameStop madness, Robinhood backlash, and limitless questions on how the SEC and Congress will respond. A solution for this entire market dislocation will take time and that could suggest this insane trading will continue a little while longer.

US stocks are poised for the worst week since the before the US presidential election as ludicrous retail trading shows no signs of ebbing. There was a lot of froth in the stock market before retail traders took GameStop and other companies with terrible fundamentals to astronomical valuations. Wall Street is broken and despite a dovish Fed, a trillion dollars in fiscal support being just around the corner, strong mega-cap tech earnings, and positive vaccine news, a shift in drivers on Wall Street is triggering a strong red wave of risk aversion across the board.

Vaccines

J&J's one-shot, easily refrigerated COVID vaccine provided another round of great news for the fight against coronavirus. Initially risk appetite focused on the 66% efficacy against COVID in a large 43,783 global trial, but once investors processed the entire study, and realized it was effective against severe infections, optimism returned. Moderna and Pfizer set the bar high with their COVID vaccines being over 90% effective against infection, but that doesn't mean J&J's will not change the global vaccination landscape. J&J's COVID vaccine is 85% effective against severe infections and complete protection against COVID hospitalizations and death.

Covavax also delivered strong results with their 15,000 study showing the COVID vaccine having a 89.3% effective prevention of symptomatic Covid-19. Covavax was 60% effective with HIV negative participants in its second trial in South Africa. Virus variants will complicate how soon we return to pre-pandemic life, but so far optimism remains in large parts of the world that a return to normal is closer to the end of the year.

Oil

Crude prices got a double dose of good news on the demand front after J&J and Novavax delivered positive late stage studies with COVID vaccines. The world’s vaccine supply problem will greatly improve now that we have two more vaccines added to the arsenal. Despite good news on the COVID vaccine front, oil prices are not immune to a general risk-off tone that is hitting financial markets. The vaccine news however is not all positive as Germany maintains their AstraZeneca COVID vaccine shot recommendation for individuals between 18-64 years old.

While the US is slowly moving beyond the holiday season peak in new cases, the decline of new infections is slowing, and concerns remain elevated that the virus variants are spreading nationwide. Short-term risks remain to the crude demand outlook and dollar positioning suggests a rebound could provide a tentative headwind for commodities. The narrative has not changed much for WTI crude and that should suggest the current consolidation can last a little while longer.

Gold

Gold prices were all over the map today as investors scratched their heads on how to react to the J&J vaccine news, a resumption of the GameStop stock trading mania, rising inflation data, and as global stocks post the worst decline since just before the US presidential election. Gold is playing tug-of-war at the $1,850 level and when all the dust settles prices should settle higher given positive developments with the reflation trade. The core PCE deflator surged 0.3% from a flat reading in the prior month. The higher the baseline for inflation before the return to pre-pandemic life, the stronger traders will pile back into gold for their inflationary hedges.

It seems gold could start to climb higher as long as a massive dollar short squeeze doesn’t occur and a significant stock market selloff triggers panic selling for the precious metal. Wall Street turned volatile thanks to GameStop Mania and if that type of trading translates into a wave of retail bets for silver, that could prove somewhat negative for gold over the next couple of weeks.

Bitcoin

Elon Musk changing of his twitter bio to Bitcoin unleashed his army of followers to pile back into the world’s largest cryptocurrency. You can also say he is responsible for taking the global crypto market cap back above $1 trillion. Bitcoin got lost in the GameStop mania and Musk’s tweet brought cryptos back into the limelight. Bitcoin is slowly making its way closer towards $40,000 and that will be the true test if this consolidation period is over. For Bitcoin to shine, retail stonk trading needs to ease and that seems like that could be happening in the not too distant future.

Author

Ed Moya

MarketPulse

With more than 20 years’ trading experience, Ed Moya is a market analyst with OANDA, producing up-to-the-minute fundamental analysis of geo-political events and monetary policies in the US, Europe, the Middle East and North Africa.

GBP/USD remains offered; bears target 1.3600

GBP/USD now leaves behind part of its recent recovery and revisits the low 1.3600s at the beginning of the week. Indeed, Cable trades with a mild downward bias amid decent gains in the Greenback as investors remain wary of upcoming US data releases and the Jackson Hole event.

EUR/USD remains sidelined above 1.1650

EUR/USD trades on the defensive following the closing bell on Wall Street on Monday, hovering around the 1.1660 region and adding to Friday’s small decline. The pair’s pullback comes in response to an acceptable rebound in the US Dollar in a context of generalised caution ahead of key US data releases and Chair Warsh’s speech in Jackson Hole.

Gold poised to extend its bullish run

Gold surrenders part of its initial advance, although it keeps its bullish pace well and sound above the $4,600 mark per troy ounce on Monday. The precious metal’s move higher comes despite slight gains in the US Dollar and a modest pullback in US Treasury yields across the curve.

XRP surged 72%, but is the rally really about XRP?

Ripple (XRP) surged more than 72% in less than a week, its strongest rally since July 2025, as cryptocurrency prices broadly broke out. But the move has a problem: it may have little to do with XRP itself. The token's near-term rally appears to have been driven largely by a broader liquidity shift after the US Treasury expanded long-end bond buybacks, pulling yields lower and lifting risk assets.

Convulsion in credit markets

The United States government just posted a $432.3 billion deficit for July, the largest monthly shortfall since March of 2021. That single burst of red ink pushed the yeartodate deficit to $1.8 trillion, with two months still remaining in fiscal 2026. At this pace, Washington will soon wax nostalgic for the “good old days” when annual deficits were only $2 trillion.

$20 billion offered, $2 billion taken: Why Treasury doubled its buyback cap

The US Treasury moved off its own calendar on Wednesday, and that is the part worth sitting with. At 12:32 GMT, the department said it would at least double the size of liquidity support buyback operations in the 10-year to 20-year and 20-year to 30-year sectors, lifting the maximum from $2 billion per operation to at least $4 billion, effective September 9 and running to November 4.